Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

Vertex plans to charge a wholesale price of $15.50 per 50-mg pill for Journavx, and the U.S. FDA approval in the acute pain indication could also bode well for winning future approval for the drug ...

Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the ...

This photo provided by Vertex Pharmaceuticals in January 2025 shows a tablet and bottle of the JOURNAVX (suzetrigine) medication.

This photo provided by Vertex Pharmaceuticals in January 2025 shows a tablet and bottle of the JOURNAVX (suzetrigine) medication. (Vertex Pharmaceuticals via AP) ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) reports Q1 earnings with $4.32 EPS and $2.85B revenue. ... 24.48% YTD, riding bullish momentum as investors eye Alyftrek and Journavx launch.

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.